How nerves affect the progression of pancreatic cancer
Peripheral Nerve Regulation of Pancreas Cancer Progression
This study is looking at how the nerves in the pancreas might affect the growth of pancreatic cancer and whether blocking these nerves could help slow down the disease, with the goal of finding new ways to improve treatment for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10979425 on NIH RePORTER |
What this research studies
This research investigates the role of sensory nerves in the progression of pancreatic cancer, particularly how their denervation may slow or stop the transition from precancerous stages to malignant disease. Using a transgenic mouse model, the study will explore the interactions between sensory nerves and immune cells within the tumor microenvironment, focusing on immune checkpoint proteins expressed by these nerves. Additionally, it will assess changes in the innervation of lymph nodes and their potential as therapeutic targets or prognostic biomarkers. The findings aim to uncover novel strategies for improving treatment efficacy in pancreatic cancer patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with pancreatic cancer or those at high risk for developing the disease.
Not a fit: Patients with non-cancerous conditions or those not diagnosed with pancreatic cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic approaches that enhance treatment outcomes for pancreatic cancer patients.
How similar studies have performed: Previous research has shown promising results in understanding the role of the nervous system in cancer, suggesting that this approach may yield significant insights.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Saloman, Jami Lynn — University of Pittsburgh at Pittsburgh
- Study coordinator: Saloman, Jami Lynn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.